- Home
- MLEC vs AEON Comparison
MLEC vs AEON Comparison
Compare MLEC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLEC
- AEON
- Stock Information
- Founded
- MLEC 2008
- AEON N/A
- Country
- MLEC Luxembourg
- AEON United States
- Employees
- MLEC N/A
- AEON N/A
- Industry
- MLEC Blank Checks
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- MLEC Finance
- AEON Health Care
- Exchange
- MLEC Nasdaq
- AEON Nasdaq
- Market Cap
- MLEC 32.8M
- AEON 36.4M
- IPO Year
- MLEC N/A
- AEON N/A
- Fundamental
- Price
- MLEC $0.85
- AEON $0.61
- Analyst Decision
- MLEC Strong Buy
- AEON Strong Buy
- Analyst Count
- MLEC 1
- AEON 1
- Target Price
- MLEC $6.00
- AEON $5.00
- AVG Volume (30 Days)
- MLEC 11.2K
- AEON 90.7K
- Earning Date
- MLEC 12-12-2024
- AEON 11-13-2024
- Dividend Yield
- MLEC N/A
- AEON N/A
- EPS Growth
- MLEC N/A
- AEON N/A
- EPS
- MLEC N/A
- AEON N/A
- Revenue
- MLEC $5,625,124.00
- AEON N/A
- Revenue This Year
- MLEC $20.42
- AEON N/A
- Revenue Next Year
- MLEC $30.00
- AEON N/A
- P/E Ratio
- MLEC N/A
- AEON N/A
- Revenue Growth
- MLEC 521.53
- AEON N/A
- 52 Week Low
- MLEC $0.75
- AEON $0.60
- 52 Week High
- MLEC $3.25
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- MLEC 46.82
- AEON 28.19
- Support Level
- MLEC $0.83
- AEON $0.65
- Resistance Level
- MLEC $0.91
- AEON $0.88
- Average True Range (ATR)
- MLEC 0.04
- AEON 0.07
- MACD
- MLEC -0.00
- AEON -0.03
- Stochastic Oscillator
- MLEC 52.06
- AEON 1.75
About MLEC Moolec Science SA
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.